High Flow Oxygen Therapy Devices And Cannula Market size was valued at USD 1.8 billion in 2021 and is expected to reach USD x million by 2028, at a CAGR of 6.8% during the forecast period 2022-2028. Due to the mounting frequency of CPOD and other respiratory diseases. Moreover, the growing elderly population and increasing cases of accidents are also surging the growth of the market. More than 65 million of the population is affected by moderate-to-severe COPD. High-flow oxygen therapy (HFOT) is an innovative and non-invasive approach for the treatment of patients suffering from acute or chronic respiratory failure. This report studies the market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the market report includes competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities.
For instance, in November 2017, Flexicare Limited a leading UK headquartered manufacturer of medical devices has acquired Medisize B.V.